NVIDIA Corporation (NVDA) vs Zepp Health Corporation (ZEPP)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| NVDA | ZEPP | |
|---|---|---|
| Sector | Technology | Technology |
| Industry | Semiconductors | Consumer Electronics |
| Size band | MEGA | NANO |
| Listing | Nasdaq GS | NYSE |
| Country | United States | Netherlands |
| Theme | ai-chips | iot-platforms |
| Price and returns | ||
| Last close | $216.00 | $2.54 |
| Return · 1 week | −0.50% | −13.01% |
| Return · 1 month | −5.62% | −34.70% |
| Return · 3 months | +9.64% | −45.26% |
| Return · year to date | +14.38% | −90.94% |
| Return · 1 year | +12.81% | −94.48% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −11.25% | −95.02% |
| 52-week high | $243.37 | $51.00 |
| 52-week low | $164.27 | $2.23 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $5.22T | $37.25M |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $22.56B | $69.09K |
| Employees | 42,000 | 763 |
| Valuation | ||
| Price to earnings · trailing | 27.63× | n/a (negative earnings) |
| Price to earnings · forward | 14.02× | n/a (negative forward earnings) |
| Price to sales | 17.40× | 0.16× |
| Price to book | 23.02× | 0.26× |
| Enterprise value to EBITDA | 26.02× | n/a (negative EBITDA) |
| Enterprise value to revenue | 17.29× | 0.41× |
| PEG ratio | 0.46 | — |
| Earnings per share · trailing | 7.90 | -6.08 |
| Profitability | ||
| Gross margin | 74.67% | 38.58% |
| Operating margin | 66.24% | −19.37% |
| Profit margin | 63.66% | −15.78% |
| Return on equity | 117.21% | −21.23% |
| Return on assets | 53.57% | −3.92% |
| Growth | ||
| Revenue growth | +105.90% | +6.90% |
| Earnings growth | +127.80% | — |
| Balance sheet and payout | ||
| Debt / equity (%) | 16.97 | 72.61 |
| Current ratio | 4.59 | 0.90 |
| Dividend yield | 0.46% | 0.00% |
| Payout ratio | 3.54% | 0.00% |
| Trend and volatility | ||
| RSI · 14 | 44.12 | 39.57 |
| ADX · 14 | 18.90 | 30.78 |
| 50-day average | $222.30 | $4.91 |
| 200-day average | $203.82 | $13.61 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 2.84% | 13.68% |
The full NVDA analysis
Everything this table leaves out for NVIDIA Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the NVDA argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full NVDA analysisThe full ZEPP analysis
Everything this table leaves out for Zepp Health Corporation: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the ZEPP argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full ZEPP analysis